# LUMISIGHT
> **NDA214511** · New Drug Application · Sponsor: LUMICELL · Approved 2024-04-17
## Drug
- **FDA Application Number:** NDA214511
- **Application type:** New Drug Application
- **Brand name:** LUMISIGHT
- **Generic name:** PEGULICIANINE
- **Active ingredients:** PEGULICIANINE ACETATE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** LUMICELL
- **Manufacturer:** Lumicell, Inc.
- **First approval:** 2024-04-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214511)
---
*AI Analytics · CC0 1.0*